• MXiPr Research Chemical Arylcyclohexylamine NMDA Antagonist
  • MXiPr Research Chemical Arylcyclohexylamine NMDA Antagonist
  • MXiPr Research Chemical Arylcyclohexylamine NMDA Antagonist
  • MXiPr Research Chemical Arylcyclohexylamine NMDA Antagonist
  • MXiPr Research Chemical Arylcyclohexylamine NMDA Antagonist
  • MXiPr Research Chemical Arylcyclohexylamine NMDA Antagonist

MXiPr Research Chemical Arylcyclohexylamine NMDA Antagonist

MXiPr (3-MeO-2'-Oxo-PCiPr, Methoxisopropamine, Isopropyloxetamine,Isopropyxetamine)is a dissociative drug of the arylcyclohexylamine class actingas an NMDA receptor antagonist. This designer drug first appeared in 2020 as aresearch substance developed as a replacement for MXE. Studies in mice haveshown that MXiPr acts as an NMDA receptor antagonist and is also a serotoninreuptake...
  • MXiPr Research Chemical Arylcyclohexylamine NMDA Antagonist
  • MXiPr Research Chemical Arylcyclohexylamine NMDA Antagonist
  • MXiPr Research Chemical Arylcyclohexylamine NMDA Antagonist

Description

Product Description

Functional Role and Intended Researchers of MXiPr

MXiPr, known chemically as methoxisopropamine, functions primarily as an NMDA receptor antagonist and belongs to the arylcyclohexylamine class of dissociatives. Designed for professional investigators and academic laboratories, this compound facilitates exploration into dissociative mechanisms and novel neurochemical interactions. Our role as a trustworthy research chemicals supplier ensures that MXiPr is delivered with consistent purity, supporting precise experimentation in pharmacological and neuropharmacological studies. This material is tailored to researchers investigating receptor antagonist behaviors and potential therapeutic analogs related to ketamine derivatives.

Technical Specifications and Measurable Attributes of MXiPr

This product possesses a molecular weight of 261.36 g/mol with ≥98% purity, presenting as a crystalline solid soluble in DMF, MSO, ethanol, and PBS, supporting diverse laboratory protocols. MXiPr’s chemical nomenclature—3-MeO-2'-Oxo-PCIPr—and CAS number 2666932-55-2 allow unambiguous identification across chemical databases. The compound’s solubility data (e.g., 20 mg/ml in DMF) and long-term storage stability at -20°C with a shelf life exceeding four years ensures suitability for extended study designs. Such quantitative parameters offer researchers reliable reproducibility when integrating this arylcyclohexylamine derivative within diverse assay formats or formulation development workflows.

Industrial and Research Applications Demonstrating MXiPr’s Utility

MXiPr supports a spectrum of scientific endeavors, including receptor function profiling, toxicological screening for novel psychoactive substances, and serotonin reuptake inhibition studies. Its pharmacodynamic profile enables comparison alongside ketamine and methoxetamine analogs, providing critical data for new psychoactive substance assessment frameworks. Additionally, MXiPr’s compatibility with various solvents and stability parameters make it advantageous for dose-response and metabolism studies in preclinical neuroscience research. As supplied by an experienced research chemicals vendor and research chemicals supplier, it contributes essential value to laboratories aiming to advance knowledge within arylcyclohexylamine research domains.


Product Advantages

Structural and Design Advantages of MXiPr’s Molecular Composition

MXiPr’s structure incorporates a distinctive isopropyl substitution on the nitrogen atom paired with a methoxy group on the phenyl ring, distinguishing it within the arylcyclohexylamine class. This molecular configuration imparts selective NMDA receptor antagonism, facilitating targeted receptor interaction studies. The crystalline solid formulation ensures uniform particle size and molecular integrity, facilitating consistent batch-to-batch performance. Sourced from a dependable research chemicals supplier, the product reflects rigorous quality control measures and authenticated purity (≥98%), supporting seamless integration into advanced chemical and pharmacological systems requiring precise structural specificity.

Performance Characteristics Enhancing Research Efficacy

The compound’s performance as an NMDA receptor antagonist with dissociative and sedative characteristics provides researchers with measurable, reproducible effects within controlled environments. MXiPr’s solubility in multiple solvents allows adaptation for a variety of analytic and bioassay platforms, thereby increasing experimental flexibility. High purity grading and prolonged storage stability reinforce its usability as a reliable reference substance over extended research periods. This chemical profile maximizes operational efficiency for laboratories engaged in neuropharmacological studies and novel compound screening implemented by specialized research chemicals vendors.


Use Scenarios

Preclinical Pharmacological Research and Receptor Profiling

In preclinical pharmacology environments, MXiPr serves as a critical compound for investigating NMDA receptor antagonism and its related neurochemical pathways. Research laboratories focused on neuropsychiatric drug development utilize this product due to its stable physicochemical properties and verified quality from an established research chemicals supplier. Its crystalline form and solvent solubility accommodate diverse assay techniques, enabling integration into receptor binding affinity studies and toxicity profiling. This ensures compliance with experimental rigor and facilitates data comparability within broader neuroscience research frameworks investigating arylcyclohexylamine dissociatives.

Toxicological and Metabolic Analysis in Research Settings

Toxicologists and pharmacokinetic researchers employ MXiPr to evaluate dose-response dynamics, metabolism rates, and potential adverse effects of new psychoactive substances related to the arylcyclohexylamine family. The product’s purity and documented chemical identity (including CAS number 2666932-55-2) meet regulatory standards necessary for validated testing protocols. MXiPr’s compatibility with analytical solvents like DMF and ethanol supports diverse extraction and chromatography workflows crucial for metabolic assessments. This aligns with evolving industry requirements for innovative compound characterization, ensuring seamless integration into preclinical safety and efficacy testing sequences.


  • MXIPr (3-MeO-2'-Oxo-PCIPr, Methoxisopropamine, Isopropyloxetamine, Isopropyxetamine) is a dissociative drug of the arylcyclohexylamine class acting as an NMDA receptor antagonist.
  • This designer drug first appeared in 2020 as a research substance developed as a replacement for MXE.
Chemistry
  • MXIPr is a derivative of drugs such as ketamine and methoxetamine.
  • MXIPr contains an isopropyl group on the nitrogen atom of the molecule and an oxygen atom at the 2' position of the cyclohexyl ring, as well as a methoxy group at the 3 position of the phenyl ring.
Pharmacology
  • The data on the toxicological and farmcological properties of MXIPr are incomplete.
  • Studies in mice have shown that MXIPr acts as an NMDA receptor antagonist and is also a serotonin reuptake inhibitor. This drug causes dissociative, sedative and euphoric effects.
  • Dosage:
    • Threshold 5 mg
    • Light 10 - 20 mg
    • Common 20 - 40 mg
    • Strong 40 - 60 mg
    • Heavy 60 mg +
  • Exposure time:
    • Total 2 - 5 hours
    • Onset 20 - 60 minutes
    • After effects 4 - 48 hours
Legal status
  • DE: NpSG (Industrial and scientific use only)
  • UK: Class B
  • CA: Schedule I
  • Hungary: Not legal
Technical Information:
  • Product Name: MXIPr
  • Synonyms: 3-MeO-2'-Oxo-PCIPr, Methoxisopropamine, Isopropyloxetamine, Isopropyxetamine
  • CAS: 2666932-55-2
  • IUPAC: 2-(3-methoxyphenyl)-2-(propan-2-ylamino)cyclohexan-1-one
    • 2-(isopropylamino)-2-(3-methoxyphenyl)cyclohexan-1-one
  • Molecular Formula: C₁₆H₂₃NO₂
  • Molecular Weight: 261.36 g/mol
  • Purity: 98.0 % min.
  • Formulations: A crystalline solid
  • Solubility:
    • DMF: 20 mg/ml
    • MSO: 10 mg/ml
    • Ethanol: 20 mg/ml
    • PBS (pH 7.2): 2 mg/ml
  • InChI: InChI=1S/C16H23NO2/c1-12(2)17-16(10-5-4-9-15(16)18)13-7-6-8-14(11-13)19-3/h6-8,11-12,17H,4-5,9-10H2,1-3H3
  • InChIKey: FTQIVDGNXPEKP-UHFFFAOYSA-N
  • SMILES: CC(C)NC1(CCCCC1=O)C2=CC(=CC=C2)OC
  • Storage: -20°C
  • Stability: ≥ 4 years
 
 
You can buy MxiPr online from ChainChemical right now.! Our company has extensive scientificexperience in chemicalresearch and market trading.
Shopping at ChainChemical:
Proven and tested products.
A unique selection of products for research and scientific solutions.
High quality and optimal cost.
A chemical product of 98-99% purity packaged in an aluminum foil bag.
Payment using Bitcoin, Monero, Etherium, Litecoin, USDT and other cryptocurrencies.

FAQ

What purity level can I expect when purchasing MXiPr from you?

We supply MXiPr with a guaranteed purity of at least 98%, ensuring consistent quality for your research needs. Our rigorous quality control processes support stable production of high-grade research chemicals like MXiPr.

Do you provide technical support or custom solutions for arylcyclohexylamine compounds?

Yes, we offer expert consultation on arylcyclohexylamines including MXiPr. Our technical team can assist with custom production requirements or formulation advice to fit your research application.

How should MXiPr be stored to maintain its stability and shelf life?

We recommend storing MXiPr at -20°C to maintain chemical stability. Under these conditions, the product’s shelf life is stable for 4 years or more, allowing dependable long-term use in pharmacological research.

Are your shipping and packaging practices suitable for sensitive research chemicals?

Our MXiPr is packaged with strict quality assurance to preserve purity and chemical stability during transit. We ensure secure and reliable delivery suited for research chemicals suppliers serving industry clients.